Novel Molecular Glue Discovery Platform Unlocks Undruggable Cancer Targets

A scalable platform to discover molecular glue degraders has been developed, identifying the first metabolically activated glue. The approach expands protein degradation targets, enabling selective elimination of previously undruggable cancer-related proteins for therapeutic development.

The post Novel Molecular Glue Discovery Platform Unlocks Undruggable Cancer Targets appeared first on GEN - Genetic Engineering and Biotechnology News.